Fiji Kava Limited (ASX:FIJ) has seen a significant uplift on sales performance in Q3 FY22. In the interests of maintaining an informed market, FIJ provides the following preliminary estimates for sales and cash flows for the quarter ended March 31st 2022.
As the world emerges from the pandemic which has emphasised the critical importance of vaccination, Apiam Animal Health (ASX:AHX) has identified an opportunity to position Australia as leaders in autogenous vaccine manufacturing.
Fiji Kava Limited (FIJ.AX) continues to drive awareness of Fijian Noble Kava to support growth through marketing initiatives.
Apiam Animal Health Limited (ASX:AHX) has been at the forefront of animal health standards of care. But with one eye on their international counterparts, executives at Apiam foresee some major improvements in animal, customer and employee outcomes which will be driven by technology.
iQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
Fiji Kava Ltd (ASX:FIJ) has today announced an investment by BSP Life (Fiji) Ltd totalling 2 million FJD via the purchase of Convertible Notes.
Fiji Kava Ltd (ASX:FIJ), is a health and wellness company with operations in Australia, Fiji, and the USA.
